Why Claims Libraries Demonstrate Good Faith Efforts Amidst FDA Crackdowns

I had the pleasure of interviewing regulatory compliance expert, Howard Dorfman, JD, about the recent crackdowns on promotion by the FDA’s Office of Prescription Drug Promotion (OPDP).  Rising regulatory pressure has renewed scrutiny of pharmaceutical promotional materials, issuing numerous untitled and warning letters for misleading claims, overstated efficacy, and unsupported data.

Howard shared several best practices for mitigating risk and strengthening trust with regulators, agencies, and internal review teams. Claims libraries rose to the top as an effective approach to accomplish both objectives. According to Howard, a robust claims library functions as the backbone for enhancing promotional review efficiency and to strengthen a company’s compliance ecosystem by housing substantiated claims derived from approved labeling, regulatory guidance, and validated evidence.

Here is a summary of Howard’s remarks:

It’s important to have an auditable, evidence-based framework to validate that all promotional claims are substantiated and compliant.  Centralized, authoritative claims libraries are increasingly viewed as both operational enablers and regulatory safeguards, ensuring promotional content is accurate, traceable, and defensible.

1. Defensible Compliance Framework: Claims libraries demonstrate a company’s commitment to compliance by:

  • Enforcing the use of only approved claims in promotional content

  • Anchoring every claim to its authoritative source for instant verification

  • Documenting due diligence through a formal, auditable review process

2. Protection Against Regulatory Risk:  Libraries reinforce a company’s ability to defend its materials against allegations of misleading “net impression.” They address key OPDP enforcement concerns, including:

  • Overstated efficacy, rapid therapeutic onset, and Quality-of-Life claims

  • Use of inadequate or outdated data to support promotional messages

  • Formatting and presentation issues such as font size, pace, or scene transitions

3. Continuous Monitoring and Rapid Label Updates:  A centralized library provides a systematic, traceable process to:

  • Update claims following label revisions

  • Document timely field material replacements

  • Demonstrate compliance to auditors and regulators

4. Audit Efficiency and Risk Reduction: Automated claims verification accelerates field audits, replacing manual testing with traceable, systemized confirmation that materials align with approved sources. This demonstrable diligence can:

  • Shorten audit timelines

  • Reduce exposure to penalties

  • Help avoid consent decrees by evidencing proactive compliance management

Beyond efficiency gains, the adoption of structured claims libraries signals a company’s proactive commitment to due diligence, transparency, and good faith in regulatory compliance.  In an era of heightened FDA scrutiny, claims libraries represent more than an operational convenience—they are a regulatory defense mechanism and a core governance asset. By institutionalizing verification, traceability, and accountability.

Learn more about how SecureCHEK AI can help by scheduling a short call.


About SecureCHEK AI

SecureCHEK AI is purpose-built for pharmaceutical and medical device companies to expedite essential review of regulated materials, so they impact sales sooner.  The cloud-based software seamlessly integrates with enterprise CMS/DAM platforms to accelerate MLR efficiency. 

SecureCHEK AI deploys a full hybrid model that combines Analytical AI and GenAI for superior accuracy, verifiability and auditability versus GenAI-only software solutions that risk hallucinations and inaccuracy. Rapid deployment and the user-friendly interface minimize the learning curve, making it easy to get started.

Contact us for a demo to learn how SecureCHEK AI builds libraries and executes prechecking.

Next
Next

FDA Crackdown Intensifies Need to Harness the Power of AI